Appropriateness of the Empirical Antibiotics Prescribed and Their Concordance with National Guidelines for Three Selected Infections among Cancer Patients in a Tertiary Care Centre in Sri Lanka
Table 2
Susceptible proportions of Enterobacteriaceae (coliforms) in each infection group.
Susceptible proportion (%)
LRTI (n = 34)
SSTI (n = 23)
UTI (n = 33)
Ciprofloxacin
14.7
13.0
15.2
Co-trimoxazole
26.1
30.3
Co-amoxiclav
2.9
4.3
9.1
Gentamycin
73.5
30.4
48.5
Cefuroxime
2.9
13
18.2
Amikacin
73.5
65.2
81.8
Imipenem/meropenem
47.1
60.9
60.6
Piperacillin-tazobactam
23.5
52.2
30.3
Ticarcillin-clavulanic acid
11.8
15.2
Cefotaxime
14.2
13.0
18.2
Aztreonam
17.6
13.0
27.3
Nitrofurantoin
48.5
Nalidixic acid
6.1
Norfloxacin
18.2
ESBL production
8.8 (3/34)
34.8 (8/23)
21.2 (7/33)
Carbapenem resistance
50 (17/34)
38.8 (8/23)
36.4 (12/33)
Not tested as these are not indicated for the treatment of selected infections.
